BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Influx Healthtech Files for IPO with NSE Emerge September 11, 2024 The IPO consists of a fresh issuance of 46.32 Lakh equity shares and an Offer for Sale (OFS) of up to 13.68 Lakh equity shares by founder Munir Abdul Ganee Chandniwala.
Paras Healthcare Files INR 400 Cr IPO August 2, 2024 The OFS includes promoter Dharminder Kumar Nagar selling 29.28 Lakh equity shares and investor Commelina Ltd divesting 1.2 Cr shares.
Akums Drugs IPO Fully Subscribed on Day 1 July 31, 2024 The IPO, which opened on Tuesday with a price band of INR 646-679, saw a subscription rate of 1.37 times by the end of Day 1.
Senores Pharmaceuticals Files INR 500 Cr IPO with SEBI July 30, 2024 This IPO comprises a fresh issue of shares worth INR 500 Cr and an offer for sale (OFS) of up to 27 Lakh equity shares by the promoters and other selling shareholders, as outlined in the DRHP.
Akums Pharma Sets for INR 1,750 Cr IPO on July 30 July 25, 2024 The issue will open for subscription on July 30 and close on Aug. 1. The bidding for the anchor portion will open for a day on July 29.
Healthcare Firm Concentra Targets $3.3 Bn Valuation in US IPO July 16, 2024 It plans to sell 22.50 million shares, priced between $23 and $26 each, potentially raising up to $585 million, according to a regulatory filing.
Emcure Pharma Raised INR 583 Cr Ahead of its on IPO on 3rd July July 4, 2024 Bain Capital-backed Emcure Pharmaceuticals raised INR 583 Cr from anchor investors, one day before its initial public offering (IPO) opened for public subscription on 3rd July.
Emcure Pharmaceuticals to Launch IPO on July 3 June 28, 2024 Bain Capital-backed Emcure Pharmaceuticals is set to launch its Initial Public Offering (IPO) on July 3, 2024.
Nephrocare India to Raise INR 40 Cr Through IPO June 21, 2024 Nephrocare India plans to allocate a significant portion of the IPO proceeds to establish a 100-bed hospital in Kolkata.
Emcure Pharma Receives SEBI Nod for INR 800 Cr IPO June 21, 2024 According to Emcure Pharmaceuticals, the capital generated from the fresh issue will be allocated towards debt repayment and general corporate purposes.
Chicago-based Tempus AI Shares Surge 15% in Stock Market Debut June 17, 2024 Chicago-based Tempus AI, a healthcare company leveraging artificial intelligence for precision medicine, saw its shares jump 15% on Friday during its initial public offering (IPO) on the NASDAQ stock exchange.
Nephro Care to Raise INR 35-40 Cr via IPO Route May 27, 2024 The net proceeds from the IPO will primarily fund the establishment of a new multi-specialty hospital in Kolkata.
